Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

References

• National Institute of Neurological Disorders Amyotrophic Lateral Sclerosis Fact Sheet. http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_ALS.htm Accessed 02.06.2012
   Google Scholar
• Woolley SC, Utility of the ALS Cognitive Behavioral Screen. Neurodegen Dis Manage 2011; 1:473–479.
   Google Scholar
• Schepelmann K, Winter Y, Spottke A, et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 2010; 257:14–23.
   Web of Science ®Google Scholar
• Miller RG, Rosenberg JA, Gelinas DF et al. Practice Parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1999; 52:1311–1323.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, et al. Practice Parameter Update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218–1226.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, et al. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009: 73:1227–1233.
   PubMed Web of Science ®Google Scholar
• The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen PM, Abrahams S, Borasio GD, et al. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006; 77:948–50.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, et al. Effects of a multidisciplinary ALS clinic on survival. J Neurol Neurosurg Psychiatry 2003;74:1258–61.
   PubMed Web of Science ®Google Scholar
• Van den Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65:1264–67.
   PubMed Web of Science ®Google Scholar
• Aridegbe T, Kandler R, Walters SJ, Walsh T, Shaw PJ, McDermott CJ. The natural history of motor neuron disease: Assessing the impact of specialist care. Amyotroph Lateral Scler. 2012 May29. [Epub ahead of print].
   Google Scholar
• Rodriguez de River FJ, Oreja Guevara C, San Gallegal I et al. Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit. Neurologia. 2011;26:455–60.
   PubMed Web of Science ®Google Scholar
• Miller RG, Scholtz D, Spitalny GM, et al. Outcomes of patients with ALS in the community, new insights from the web-based ALS patient care.Amyotroph Lateral Scler 2006(1); 7:56–57.
   Google Scholar
• Miller RG, Anderson F, Brooks BR, et al. ALS CARE Study Group. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol 2009; 65(1):S24–8.
   PubMed Web of Science ®Google Scholar
• Riemenschneider K, Forshew D, Miller RG. Multidisciplinary clinics: optimizing treatment for patients with amyotrophic lateral sclerosis. Neurodegen. Dis. Manage. < 2013; 3(2):157–167.
   Google Scholar
• National Institute for Health and Clinical Excellence (NICE) Non-invasive ventilation for motor neurone disease Available at: http://guidance.nice.org.uk/nicemedia/live/13057/49885/49885.pdf Accessed 10/4/2011.
   Google Scholar
• Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006; 5:140 –147.
   PubMed Web of Science ®Google Scholar
• Heffernan C, Jenkinson C, Holmes T. et al., Management of respiration in MND/ALS patients: An evidence based review. Amyotroph Lateral Scler 2006; 7(1): 5–15.
   PubMed Web of Science ®Google Scholar
• Bradley WG, Anderson F, Gowda N, Miller RG. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5:240–44.
   PubMed Web of Science ®Google Scholar
• Williams NM, Bravver EK, Bockenek WL, et al. The Joint Commission ( TJC ) Disease – Specific Care Certification (DSC) Program for Amyotrophic Lateral Sclerosis (ALS) – A Structured Mechanism Developed for Performance Measure Implementation, Audit, and Compliance Assessment Allowing Evolution from Process – Based to Patient – Outcome – Based Improvements in an ALS Multidisciplinary Center Available Internationally. Amyotroph Lateral Scler 2012; 13(1):40.
   Google Scholar
• American Academy of Neurology, American College of Radiology, National Committee for Quality Assurance, American Medical Association-convened Physician Consortium for Performance Improvement Stroke and Stroke Rehabilitation Performance Measurement Set. 2012. Available at: www.ama-assn.org/ama1/pub/upload/mm/pcpi/stroke-worksheets.pdf
   Google Scholar
• Cheng EM, Tonn S, Swain-Eng R, et al, for the American Academy of Neurology Parkinson's Disease Measure Development Panel. Quality improvement in neurology: AAN Parkinson's Disease Quality Measures. Neurology; 2010; 75: 2021–7.
   PubMed Web of Science ®Google Scholar
• Fountain NB, Van Ness PC, Swain-Eng RJ et al. Quality improvement in neurology: AAN Epilepsy quality measures Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology Neurology. 2011; 76: 94–99.
   Google Scholar
• Bever CT, Dubinsky R, Tonn S, Swain-Eng R, for the Quality Measures and Reporting Subcommittee. Quality Measure Development Process Manual 2010 Edition. Approved by the AAN Board of Directors in December 2010. Available at: www.aan.com/practice/quality-measures/about-quality-measures
   Google Scholar
• Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD001447. DOI: 10.1002/14651858.CD001447.pub3.
   Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE) Guidance on the Use of Riluzole (Rilutek) for the Treatment of Motor Neuron Disease, Available at: guidance.nice.org.uk/nicemedia/live/11415/32139/32139.pdf
   Google Scholar
• Norris F: The “Ten Commandments” for Optimal Motor Neuron Disease Patient Care Available at: http://www.cpmc.org/services/als/about/als_ten.html
   Google Scholar
• Hardiman O, Traynor BJ, Corr B, Frost E. Models of care for motor neuron disease: setting standards. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002; 3(4):182–5.
   PubMed Web of Science ®Google Scholar
• Radunović A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol. 2007; 6(10):913–25.
   PubMed Web of Science ®Google Scholar
• Corcia P, Bourdillon F. Evaluation of the national reference center for support of amyotrophic lateral sclerosis (ALS ) in Paris on Société Francaise de Santé Publique [French Society of Public Health]2008; Available at: http://www.sfsp.fr/activites/file/rapportSLA.pdf
   Google Scholar
• National Institute for Health and Clinical Excellence.. NICE quality standards and clinical audit Available at: www.nice.org.uk/media/835/EC/NICEQualityStandardsAndAudit.pdf
   Google Scholar
• ALS-Care http://www.neurodegenerationresearch.eu/initiatives/2012-joint-transnational-calls/closed-calls/healthcare-evaluation-2012/call-results/als-care/
   Google Scholar